Vaginal misoprostol prior to insertion of an intrauterine device: An RCT

Human Reproduction

Volumn 26, Issue 2, 2011, Pages 323-329

  Dijkhuizen, Kirsten ^a   Dekkers, Olaf M ^a   Holleboom, Cas A G ^b   De Groot, Christianne J M ^b   Hellebrekers, Bart W J ^c   Van Roosmalen, Godelieve J J ^a   Janssen, Catharina A H ^d   Helmerhorst, Frans M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

^c HAGA HOSPITAL   (Netherlands)

^d GROENE HART HOSPITAL   (Netherlands)

Author keywords

cervical priming; intrauterine device; intrauterine device insertion; misoprostol (vaginal)

Indexed keywords

LEVONORGESTREL; MISOPROSTOL; PLACEBO;

ABDOMINAL CRAMP; ADULT; ARTICLE; DIAPHORESIS; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSURIA; FEMALE; FEVER; HEADACHE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; OUTCOME ASSESSMENT; PAIN; PAIN ASSESSMENT; PARESTHESIA; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RISK FACTOR; SCORING SYSTEM; SIDE EFFECT; VOMITING;

EID: 79251471395     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deq348     Document Type: Article

References (28)

1. Aronsson A, Bygdeman M, Gemzell-Danielsson K. Effects of misoprostol on uterine contractility following different routes of administration. Hum Reprod 2004;19:81-84.
2. Barcaite E, Bartusevicius A, Railaite DR, Nadisauskiene R. Vaginal misoprostol for cervical priming before hysteroscopy in perimenopausal and postmenopausal women. Int J Gynaecol Obstet 2005;91:141-145.
3. Centraal Bureau voor de Statistiek (CBS). Geboorteregeling in 2008. www.cbs.nl/NR/rdonlyres/8B92B0BC-2485-40F2-BEA4-ED360A60C2A9/ 0/2009k1b15p54art.pdf (22 April 2010, date last accessed).
4. Crane JM, Healey S. Use of misoprostol before hysteroscopy: a systematic review. J Obstet Gynecol Can 2006;28:373-379.
5. D'Arcangues C. Worldwide use of intrauterine devices for contraception. Contraception 2007;75:2-7.
6. Dekkers OM, Elm EV, Algra A, Romijn JA, Vandenbroucke JP. How to assess the external validity of therapeutic trials: a conceptual approach. Int J Epidemiol 2010;39:89-94.
7. Farmer M, Webb A. Intrauterine device insertion-related complications: can they be predicted? J Fam Plann Reprod Health Care 2003; 29:227-231.
8. Fiala C, Gemzell-Dabielsson K, Tang OS, von Hertzen H. Cervical priming with misoprostol prior to transcervical procedures. Int J Gynecol Obstet 2007;99:168-171.
9. Goldberg AB, Greenberg MB, Darney PD. Misoprostol and pregnancy. N Engl J Med 2001;344:38-47.
10. Grimes DA, Mishell DR. Intrauterine contraception as an alternative to interval tubal sterilization. Contraception 2008;77:6-9.
11. Grimes DA, Lopez LM, Manion C, Schulz KF. Cochrane systematic reviews of IUD trials: lessons learned. Contraception 2007;75:S55-S59.
12. Heikinheimo O, Inki P, Kunz M, Parmhed S, Anttila AM, Olsson SE, Hurskainen R, Gemzell-Danielsson K. Double-blind, randomized, placebo-controlled study on the effect of misoprostol on ease of consecutive insertion of the levonorgestrel-releasing intrauterine system. Contraception 2010;81:481-486.
13. Hubacher D, Reyes V, Lillo RN, Zepeda A, Chen PL, Croxatto H. Pain from copper intrauterine device insertion: Randomized trial of prophylactic ibuprofen. Am J Obstet Gynaecol 2006;195:1272-1277.
14. Hurskainen R, Teperi J, Rissanen P, Aalto AM, Grenman S, Kivelä A, Kujansuu E, Vuorma S, Yliskoski M, Paavonen J. Clinical outcomes and costs with the levonorgestrel-releasing intrauterine system or hysterectomy for treatment of menorrhagia: randomized trial 5-year follow-up. JAMA 2004;291:1456-1463. (Pubitemid 38543736)
15. Jensen HH, Blaabjerg S, Lyndrup J. Profylaktisk brug af prostaglandinesynthetasehaemmere ved oplaegning af spiral. Ungeskr Laeger 1998;160:6958-6961.
16. Li YT, Kuo TC, Kuan LC, Chu YC. Cervical softening with vaginal misoprostol before intrauterine device insertion. Int J Gynecol Obstet 2005;89:67-68.
17. Luukkainen T, Toivonen J. Levonorgestrel-releasing IUD as a method of contraception with therapeutic properties. Contraception 1995; 52:269-276.
18. Milsom I. The levonorgestrel-releasing intrauterine system as an alternative to hysterectomy in peri- menopausal women. Contraception 2007; 75:S152-S154.
19. Ngai SW, Chan YM, Liu KL, Ho PC. Oral misoprostol for cervical priming in non-pregnant women. Hum Reprod 1997;12:2373-2375.
20. Ngai SW, Chan YM, Tang OS, Ho PC. The use of misoprostol for pre-operative cervical dilatation prior to vacuum aspiration: a randomized trial. Hum Reprod 1999;14:2139-2142.
21. Oppegaard KS, Qvigstad E, Nesheim BI. Oral versus self-administered vaginal misoprostol at home before surgical termination of pregnancy: a randomised controlled trial. BJOG 2006;113:58-64.
22. Preutthipan S, Herabutya Y. A randomized controlled trial of vaginal misoprostol for cervical priming before hysteroscopy. Obstet Gynecol 1999;94:427-430.
23. Preutthipan S, Herabutya Y. A randomized comparison of vaginal misoprostol and dinoprostone for cervical priming in nulliparous women before operative hysteroscopy. Fertil Steril 2006;86:990-994.
24. Sääv A, Aronsson A, Marions L, Stephansson O, Gemzell-Danielsson K. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized trial. Hum Reprod 2007;22:2647-2652.
25. Schulz KF, Grimes DA. Sample size calculations in randomised trials: mandatory and mystical. Lancet 2005;365:1348-1353.
26. Singh K, Fong YF. Preparation of the cervix for surgical termination of pregnancy in the first trimester. Hum Reprod Update 2000; 6:442-448.
27. Sriwatanakul K, Kelvie W, Lasagna L, Calimlim JF, Weis OF, Mehta G. Studies with different types of visual analog scales for measurement of pain. Clin Pharmacol Ther 1983;34:234-239.
28. Wing DA, Gaffaney CA. Vaginal misoprostol administration for cervical ripening and labor induction. Clin Obstet Gynecol 2006;49: 627-641.